GlycoMimetics Inc (GLYC)
0.2337
+0.03
(+13.72%)
USD |
NASDAQ |
Dec 20, 16:00
0.23
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Market Cap: 15.07M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Biomarin Pharmaceutical Inc | 12.52B |
Arbutus Biopharma Corp | 608.27M |
Revance Therapeutics Inc | 323.10M |
FibroGen Inc | 40.31M |
Cidara Therapeutics Inc | 254.00M |
Market Cap Related Metrics
Price to Book Value | 1.325 |
Price | 0.2337 |
Earnings Yield | -265.3% |